Businesses and business organizations, through participation in the Institute, take an active role in shaping the Institute's policies and directing its program of action. Our agenda reflects our members' priorities and our influence is a measure of their commitment. You are cordially invited to participate in the Institute and to experience the benefits of membership.

Background

In March 1989, four prominent members of the U.S. Chamber of Commerce joined together to create a coalition to serve the common interests of employers and employees in preventing drug abuse and its impact on the American workplace. That coalition — THE INSTITUTE FOR A DRUG-FREE WORKPLACE — now includes many of the largest companies in the United States, as well as many other businesses and business organizations.

Purpose

The Institute represents much of what is best about the American business community; dedication by top business leaders, creativity and vigor in addressing a national problem, commitment to the fairness and integrity of individual corporate programs, a fundamental confidence in American workers, and a willingness to act altruistically and cooperatively to assist each other and better our society.

The Instiute — through and by its members — believes that the business community has a leading and highly legitimate role in preventing drug abuse, and that employers are fully capable of winning their "war on drugs".

The results are undeniable — the Institute is a consistent and unwavering national force on drug-abuse prevention policy issues.

"Nobody has taken a tougher, more intelligent, or more vigorous stand against drugs in the workplace; in advertising and promoting what works; and in debunking many of the myths about drugs in the workplace... the Institute for a Drug-Free Workplace has performed a valuable public service."

— William J. Bennett
Former Director
Office of National Drug Control Policy

• Subscription to the Institute's "Updates" series, including:
  • Legal Updates track court decisions affecting employers' rights to drug test.
  • Legislative Updates follow key drug-testing legislation as it is introduced and enacted into law at the state and federal levels.
  • Regulatory Updates examine new and revised government requirements such as the DoT regulations and the HHS Guidelines.
  • Research Study & Surveys Updates profile new studies and surveys on drug trends, including the HHS National Household Survey, the DAWN Report, and the SmithKline Beecham Drug-Testing Index, among others.
• "Standing Order" for single complimentary copies of all new Institute publications
• 15% discount on additional purchases of Institute publications
• Participation in the Institute's annual meeting
• Participation in "industry" and "subject" forums
• Information on how to minimize your program's vulnerability to legal challenges
• Assistance in developing and implementing employee drug education/awareness programs.
• Information on employee attitudes as gathered through Institute/Gallup surveys
• Information and suggestions regarding company drug abuse prevention efforts.
• Legislative alerts to facilitate timely communication of your views to various legislatures regarding drug testing legislation.
• Opportunity to network with public policy-makers
• Opportunity to network with Institute members
• Opportunity to network through state and local chambers, trade associations, and business coalitions